Complement components C3, C3a, C3b/iC3b, Ba, C5, and CFB levels were significantly upregulated within the early/intermediate AMD group in comparison with controls (P for all ≤ 0.05, Table 1). The gene discussed is C5; the disease is age-related macular degeneration.